Artificial intelligence for diabetes care: current and future prospects.

Journal: The lancet. Diabetes & endocrinology
Published Date:

Abstract

Artificial intelligence (AI) use in diabetes care is increasingly being explored to personalise care for people with diabetes and adapt treatments for complex presentations. However, the rapid advancement of AI also introduces challenges such as potential biases, ethical considerations, and implementation challenges in ensuring that its deployment is equitable. Ensuring inclusive and ethical developments of AI technology can empower both health-care providers and people with diabetes in managing the condition. In this Review, we explore and summarise the current and future prospects of AI across the diabetes care continuum, from enhancing screening and diagnosis to optimising treatment and predicting and managing complications.

Authors

  • Bin Sheng
    MOE Key Laboratory of AI, School of Electronic, Information, and Electrical Engineering, Shanghai Jiao Tong University, Shanghai, China.
  • Krithi Pushpanathan
    Centre for Innovation and Precision Eye Health, Yong Loo Lin School of Medicine, National University of Singapore and National University Health System, Singapore.
  • Zhouyu Guan
    Shanghai International Joint Laboratory of Intelligent Prevention and Treatment for Metabolic Diseases, Department of Computer Science and Engineering, School of Electronic, Information, and Electrical Engineering, Shanghai Jiao Tong University, Department of Endocrinology and Metabolism, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai Diabetes Institute, Shanghai Clinical Center for Diabetes, Shanghai 200240, China.
  • Quan Hziung Lim
    Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
  • Zhi Wei Lim
    Centre for Innovation and Precision Eye Health, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
  • Samantha Min Er Yew
    Centre for Innovation and Precision Eye Health, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
  • Jocelyn Hui Lin Goh
    Centre for Innovation and Precision Eye Health, Yong Loo Lin School of Medicine, National University of Singapore and National University Health System, Singapore.
  • Yong Mong Bee
    1Department of Endocrinology, Singapore General Hospital, Singapore.
  • Charumathi Sabanayagam
    Singapore National Eye Centre, Singapore Eye Research Institute, Singapore, Singapore.
  • Nick Sevdalis
    Centre for Behavioural and Implementation Science Interventions, National University of Singapore, Singapore.
  • Cynthia Ciwei Lim
    Department of Renal Medicine, Singapore General Hospital, 168753, Singapore.
  • Chwee Teck Lim
    NUS Graduate School for Integrative Sciences & Engineering, National University of Singapore, Singapore, Singapore. ctlim@nus.edu.sg.
  • Jonathan Shaw
    North Carolina Wildlife Resources Commission, Raleigh, NC, USA.
  • Weiping Jia
    Department of Endocrinology and Metabolism, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai Clinical Center for Diabetes, Shanghai Key Laboratory of Diabetes Mellitus, Shanghai Diabetes Institute Shanghai 200233, China.
  • Elif Ilhan Ekinci
    Australian Centre for Accelerating Diabetes Innovations, Melbourne Medical School and Department of Medicine, University of Melbourne, Melbourne, VIC, Australia; Department of Endocrinology, Austin Health, Melbourne, VIC, Australia.
  • Rafael Simó
    Endocrinology and Nutrition Department, Hospital Universitari Vall D´Hebron, Barcelona, Spain.
  • Lee-Ling Lim
    Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
  • Huating Li
    Shanghai Jiao Tong University Affiliated Sixth People's Hospital, China. Electronic address: huarting99@sjtu.edu.cn.
  • Yih-Chung Tham
    Singapore Eye Research Institute, Singapore National Eye Centre, Singapore; Ophthalmology and Visual Sciences Academic Clinical Program (Eye ACP), Duke-NUS Medical School, Singapore.